HOME
 
Piracetam
 
CDP choline
 
Vinpocetine
 
Idebenone
 
Galantamine
 
Modafinil
 
Deprenyl
 
Pyritinol
 
to Order
 
 
 
 
 



































 




Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon

Kuchmerovskaia TM, Parkhomets PK, Donchenko GV, Obrosova IG, 
Klimenko AP, Kuchmerovskii NA, Pakirbaeva LV, Efimov AS.

[Article in Russian]

Institute of Biochemistry, Kiev.

Abstract

Streptosotocin-induced diabetes in rats is accompanied by the development of diabetic complications such as neuropathies. [2-14C]serotonin and [U-14C]GABA release from the neurotransmitter pre-loaded synaptosomes showed significant elevation.  Aldose reductase inhibitors (AL-1576, sorbinil) administration leads to partial restoration of serotonin and GABA release, while picamilon restored only GABA release.  It was shown that Na+,K(+)-ATPase activities decreased in synaptosomes, synaptic membranes and sciatic nerve of diabetic rats compared to control.  Administration of AL-1576 normalized Na+, K(+)-ATPase activity, while sorbinil and pikamilon less effectively.  Sorbitol level are increased in streptozotocin-diabetic rats as compared to control.  The pikamilon and aldose reductase inhibitors administration to diabetic rats is accompanied by the partial reduction of brain sorbitol level.  The findings confirm the important role of pikamilon and aldose reductase inhibitors in the prevention and treatment of diabetic neuropathy.

Galantamine | Vinpocetine | Idebenone 
  Pyritinol | CDP Choline | Deprenyl | Piracetam 
 Home | Order
 

 

 

Hit Counter